News
Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.
WEIGHT-LOSS drugs can be a silver bullet for some trying to shed the pounds after years of failure with fad diets and exercise routines. But dodgy vendors selling potentially deadly fake jabs ...
For dividend-seeking investors, a buoyant stock market can be a little annoying. Stock prices rising faster than profits ...
21h
MarketBeat on MSNTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyThis week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results